Combined Fluoxetine and Metformin Treatment Potentiates Antidepressant Efficacy Increasing IGF2 Expression in the Dorsal Hippocampus
An increasing number of studies show that selective serotonin reuptake inhibitors (SSRIs) exert their therapeutic action, at least in part, by amplifying the influence of the living environment on mood. As a consequence, when administered in a favorable environment, SSRIs lead to a reduction of symp...
Ausführliche Beschreibung
Bibliographische Detailangaben
| Veröffentlicht in: | Neural plasticity. - 1998. - 2019(2019) vom: 25., Seite 4651031
|
|---|
| 1. Verfasser: |
Poggini, Silvia
(VerfasserIn) |
|---|
| Weitere Verfasser: |
Golia, Maria Teresa,
Alboni, Silvia,
Milior, Giampaolo,
Sciarria, Livio Pepè,
Viglione, Aurelia,
Matte Bon, Gloria,
Brunello, Nicoletta,
Puglisi-Allegra, Stefano,
Limatola, Cristina,
Maggi, Laura,
Branchi, Igor |
|---|
| Format: | Online-Aufsatz
|
|---|
| Sprache: | English |
|---|
| Veröffentlicht: |
2019
|
|---|
| Zugriff auf das übergeordnete Werk: | Neural plasticity
|
|---|
| Schlagworte: | Journal Article
Research Support, Non-U.S. Gov't
Antidepressive Agents
Hypoglycemic Agents
Serotonin Uptake Inhibitors
Fluoxetine
01K63SUP8D
Insulin-Like Growth Factor II
67763-97-7
Metformin
9100L32L2N |
|---|